美, 렘데시비르 3개월 치 물량 싹쓸이...EU는 확보 위한 협상 중<br /><br />The U.S. has reportedly bought nearly all the global supply of the COVID-19 drug remdesivir for the next three months.<br />CNN reported that the U.S. has secured 92 percent of the drugmaker's total production for July to September.<br />That's enough for 500-thousand treatment courses.<br />The EU is in talks to reserve doses for EU member states and is negotiating over the drug maker's production capacity.<br />Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials.<br />It's also the only drug that has an emergency use authorization from the U.S. Food and Drug Administration to treat the virus.<br />
